Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.070
+0.020 (1.90%)
At close: Jul 2, 2026, 4:00 PM EDT
1.080
+0.010 (0.93%)
After-hours: Jul 2, 2026, 7:40 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $204.13 million as of July 2, 2026. Its market cap has increased by 53.39% in one year.
Market Cap
204.13M
Enterprise Value
201.56M
1-Year Change
53.39%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $204.13M, a decrease of -60.30%. That is a compound annual growth rate of -17.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 204.13M | 42.85% |
| Dec 31, 2025 | 142.90M | 214.80% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Treace Medical Concepts | 273.12M |
| Profound Medical | 249.75M |
| RxSight | 232.23M |
| InfuSystem Holdings | 205.05M |
| Quanterix | 203.97M |
| Quantum-Si incorporated | 202.60M |
| Apyx Medical | 180.06M |
| Inogen | 178.69M |